Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/120216
Type: Journal article
Title: Vitamin D and cardiometabolic risk factors and diseases
Author: Mousa, A.
Naderpoor, N.
Teede, H.
De Courten, M.
Scragg, R.
De Courten, B.
Citation: Minerva Endocrinologica, 2015; 40(3):213-230
Publisher: Edizioni Minerva Medica
Issue Date: 2015
ISSN: 0391-1977
1827-1634
Statement of
Responsibility: 
A. Mousa, N. Naderpoor, H.J. Teede, M.P.J. De Courten, R. Scragg, B. De Courten
Abstract: Obesity, type 2 diabetes, and cardiovascular disease (CVD) are the most common preventable causes of morbidity and mortality worldwide. Insulin resistance, which is a shared feature in these conditions, is also strongly linked to the development of polycystic ovary syndrome (PCOS), which is the most common endocrine disease in women of reproductive age and a major cause of infertility. Vitamin D deficiency has reached epidemic proportions worldwide, primarily due to the shift to sedentary, indoor lifestyles and sun avoidance behaviours to protect against skin cancer. In recent years, vitamin D deficiency has been implicated in the aetiology of type 2 diabetes, PCOS and CVD, and has been shown to be associated with their risk factors including obesity, insulin resistance, hypertension, as well as chronic low-grade inflammation. Treating vitamin D deficiency may offer a feasible and cost-effective means of reducing cardiometabolic risk factors at a population level in order to prevent the development of type 2 diabetes and CVD. However, not all intervention studies show that vitamin D supplementation alleviates these risk factors. Importantly, there is significant heterogeneity in existing studies with regards to doses and drug regimens used, populations studied (i.e. vitamin D deficient or sufficient), and the lengths of supplementation, and only few studies have directly examined the effect of vitamin D on insulin secretion and resistance with the use of clamp methods. Therefore, there is a need for well-designed large scale trials to clarify the role of vitamin D supplementation in the prevention of type 2 diabetes, PCOS, and CVD.
Keywords: Vitamin D; obesity; insulin resistance; polycystic ovary syndrome; inflammation cardiovascular diseases; diabetes mellitus
Rights: Copyright Status Unknown
RMID: 0030094746
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.